Hüsnü Pullukçu

2.9k total citations
142 papers, 1.2k citations indexed

About

Hüsnü Pullukçu is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Hüsnü Pullukçu has authored 142 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Epidemiology, 47 papers in Infectious Diseases and 21 papers in Molecular Medicine. Recurrent topics in Hüsnü Pullukçu's work include Antibiotic Resistance in Bacteria (21 papers), Hepatitis B Virus Studies (16 papers) and Antifungal resistance and susceptibility (16 papers). Hüsnü Pullukçu is often cited by papers focused on Antibiotic Resistance in Bacteria (21 papers), Hepatitis B Virus Studies (16 papers) and Antifungal resistance and susceptibility (16 papers). Hüsnü Pullukçu collaborates with scholars based in Türkiye, United States and China. Hüsnü Pullukçu's co-authors include Meltem Taşbakan, Tansu Yamazhan, Sercan Ulusoy, Oğuz Reşat Sipahi, Bilgin Arda, Şöhret Aydemir, Oğuz Reşat Sıpahı, Hilal Sipahi, Raika Durusoy and Şebnem Şenol Akar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Hüsnü Pullukçu

118 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hüsnü Pullukçu Türkiye 19 760 339 315 131 124 142 1.2k
Sercan Ulusoy Türkiye 20 630 0.8× 241 0.7× 358 1.1× 139 1.1× 150 1.2× 75 1.2k
Tansu Yamazhan Türkiye 18 604 0.8× 206 0.6× 272 0.9× 93 0.7× 79 0.6× 103 1.1k
Yonit Wiener‐Well Israel 17 628 0.8× 582 1.7× 373 1.2× 102 0.8× 196 1.6× 60 1.6k
Meltem Taşbakan Türkiye 17 620 0.8× 244 0.7× 268 0.9× 90 0.7× 93 0.8× 139 1.1k
Thana Khawcharoenporn Thailand 20 762 1.0× 712 2.1× 292 0.9× 145 1.1× 209 1.7× 90 1.5k
Neşe Saltoğlu Türkiye 21 443 0.6× 444 1.3× 199 0.6× 87 0.7× 83 0.7× 97 1.3k
Lior Nesher Israel 18 577 0.8× 503 1.5× 189 0.6× 71 0.5× 65 0.5× 75 1.5k
Yu Bin Seo South Korea 22 763 1.0× 401 1.2× 218 0.7× 125 1.0× 72 0.6× 100 1.3k
Fernando Bellissimo‐Rodrigues Brazil 22 406 0.5× 679 2.0× 322 1.0× 93 0.7× 118 1.0× 92 1.6k
Hélio Caiaffa-Filho Brazil 19 533 0.7× 267 0.8× 325 1.0× 107 0.8× 100 0.8× 49 1.1k

Countries citing papers authored by Hüsnü Pullukçu

Since Specialization
Citations

This map shows the geographic impact of Hüsnü Pullukçu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hüsnü Pullukçu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hüsnü Pullukçu more than expected).

Fields of papers citing papers by Hüsnü Pullukçu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hüsnü Pullukçu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hüsnü Pullukçu. The network helps show where Hüsnü Pullukçu may publish in the future.

Co-authorship network of co-authors of Hüsnü Pullukçu

This figure shows the co-authorship network connecting the top 25 collaborators of Hüsnü Pullukçu. A scholar is included among the top collaborators of Hüsnü Pullukçu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hüsnü Pullukçu. Hüsnü Pullukçu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamazhan, Tansu, Behice Kurtaran, Oğuz Karabay, et al.. (2023). Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data. Viral Hepatitis Journal. 29(2). 58–63.
2.
Şimşir, İlgın Yıldırım, et al.. (2023). Is Having Diabetic Foot Infection a Risk Factor for Hepatitis C?. 28(3). 472–477. 1 indexed citations
3.
4.
Ekren, Pervin Korkmaz, et al.. (2021). İki Ucu Keskin Bıçak: Kolistin Yüksek Doz C Vitamini ile Nefrotoksisite Önlenebilir mi?. SHILAP Revista de lepidopterología. 26(2). 303–310. 1 indexed citations
5.
Parlak, Emine, Ferhan Kerget, Tuna Demırdal, et al.. (2021). The Epidemiology, Clinical Manifestations, Radiology, Microbiology, Treatment, and Prognosis of Echinococcosis: Results of NENEHATUN Study. Vector-Borne and Zoonotic Diseases. 21(12). 948–954. 2 indexed citations
6.
Çiçek, Candan, Deniz Gökengin, Şöhret Aydemir, et al.. (2021). Frequency of Sexually Transmitted Pathogens in HIV- Positive Individuals. Türk Mikrobiyoloji Cemiyeti Dergisi. 1 indexed citations
7.
8.
Yamazhan, Tansu, et al.. (2020). Relationship between Viral Load and Hepatic Histopathology in Patients with Chronic Hepatitis B. Viral Hepatitis Journal. 26(1). 1–4. 1 indexed citations
9.
10.
Yamazhan, Tansu, İlker Turan, Galip Ersöz, et al.. (2020). Real-life experience of ledipasvir and sofosbuvir single-tablet regimen among chronic hepatitis C patients in Turkey. The Turkish Journal of Gastroenterology. 31(3). 239–245. 2 indexed citations
11.
Kızılay, Fuat, et al.. (2019). Carbapenem-resistant Klebsiella pneumonia infection in a tertiary urology clinic: analysis of influencing factors with a controlled trial. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(1). 239–247. 2 indexed citations
12.
Pullukçu, Hüsnü, et al.. (2019). Impact of Direct Acting Antiviral Agents on Psychiatric and Sexual Health of Patients with Hepatitis C Virus. Viral Hepatitis Journal. 25(1). 25–31. 2 indexed citations
13.
Öztürk, Anıl Murat, Meltem Taşbakan, Dilek Yeşim Metin, et al.. (2019). A neglected causative agent in diabetic foot infection: a retrospective evaluation of 13 patients with fungal etiology. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(1). 81–86. 11 indexed citations
14.
Pullukçu, Hüsnü, Selda Sayın Kutlu, Onur Kaya, et al.. (2019). Multicenter Analysis of Anidulafungin Use in Invasive Candida Infections. SHILAP Revista de lepidopterología. 24(2). 136–142.
15.
Sıpahı, Oğuz Reşat, Tuna Demırdal, Aslıhan Candevir, et al.. (2018). Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: Results of the Ege study. Clinical Neurology and Neurosurgery. 172. 31–38. 17 indexed citations
16.
Can, Hüseyin, Mert Döşkaya, Mümtaz Yılmaz, et al.. (2017). Screening of immunocompromised patients at risk of strongyloidiasis in western Turkey using ELISA and real-time PCR. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(3). 897–901. 3 indexed citations
17.
Pullukçu, Hüsnü, Bilgin Arda, Mine Hekimgil, et al.. (2010). Tüberküloz lenfadenit: Üç olgu. ANKEM Dergisi. 24(3). 136–140.
18.
Pullukçu, Hüsnü, Oğuz Reşat Sıpahı, Tansu Yamazhan, Şöhret Aydemir, & Alper Tünger. (2007). 1999-2006 yılları arasında dışkı kültürlerinden izole edilen 439 Shigella kökeninin tür dağılımı ve antibakteriyel direnç durumları. ANKEM Dergisi. 21(3). 137–141. 1 indexed citations
19.
Pullukçu, Hüsnü, et al.. (2006). İdrar kültürlerinden soyutlanan bakteriler ve çeşitli antibiyotiklere in-vitro duyarlılıklarının değerlendirilmesi. ANKEM Dergisi. 20(1). 26–30. 2 indexed citations
20.
Taşbakan, Meltem, Hüsnü Pullukçu, Tansu Yamazhan, Bilgin Arda, & Sercan Ulusoy. (2004). Toplum kökenli üriner sistem infeksiyonlarından soyutlanan Escherichia coli suşlarına fosfomisinin in-vitro etkinliğinin diğer antibiyotiklerle karşılaştırılması. ANKEM Dergisi. 18(4). 216–219. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sercan Ulusoy Breakdown of academic impact, for papers by Tansu Yamazhan Breakdown of academic impact, for papers by Yonit Wiener‐Well Breakdown of academic impact, for papers by Meltem Taşbakan Breakdown of academic impact, for papers by Thana Khawcharoenporn Breakdown of academic impact, for papers by Neşe Saltoğlu Breakdown of academic impact, for papers by Lior Nesher Breakdown of academic impact, for papers by Yu Bin Seo Breakdown of academic impact, for papers by Fernando Bellissimo‐Rodrigues Breakdown of academic impact, for papers by Hélio Caiaffa-Filho
Rankless by CCL
2026